These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31496314)

  • 1. Respirable aerosol exposures of nicotine dry powder formulations to
    Sciuscio D; Hoeng J; Peitsch MC; Vanscheeuwijck P
    Inhal Toxicol; 2019 May; 31(6):248-257. PubMed ID: 31496314
    [No Abstract]   [Full Text] [Related]  

  • 2. Dry powder inhalation exposures of the endotracheally intubated rat lung, ex vivo and in vivo: the pulmonary pharmacokinetics of fluticasone furoate.
    Selg E; Ewing P; Acevedo F; Sjöberg CO; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):181-9. PubMed ID: 23094685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Lung Pharmacokinetic of the Novel PDE4 Inhibitor CHF6001 in Preclinical Models: Evaluation of the PreciseInhale Technology.
    Fioni A; Selg E; Cenacchi V; Acevedo F; Brogin G; Gerde P; Puccini P
    J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):61-70. PubMed ID: 28768120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivering horseradish peroxidase as a respirable powder to the isolated, perfused, and ventilated lung of the rat: the pulmonary disposition of an inhaled model biopharmaceutical.
    Selg E; Acevedo F; Nybom R; Blomgren B; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):273-84. PubMed ID: 20455769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of particle deposition density of dry powders on the results produced by an in vitro test system simulating dissolution- and absorption rates in the lungs.
    Malmlöf M; Nowenwik M; Meelich K; Rådberg I; Selg E; Burns J; Mascher H; Gerde P
    Eur J Pharm Biopharm; 2019 Jun; 139():213-223. PubMed ID: 30862480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline.
    Ewing P; Eirefelt SJ; Andersson P; Blomgren A; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2008 Jun; 21(2):169-80. PubMed ID: 18518793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DissolvIt: An In Vitro Method for Simulating the Dissolution and Absorption of Inhaled Dry Powder Drugs in the Lungs.
    Gerde P; Malmlöf M; Havsborn L; Sjöberg CO; Ewing P; Eirefelt S; Ekelund K
    Assay Drug Dev Technol; 2017; 15(2):77-88. PubMed ID: 28322599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel method to aerosolize powder for short inhalation exposures at high concentrations: isolated rat lungs exposed to respirable diesel soot.
    Gerde P; Ewing P; Låstbom L; Ryrfeldt A; Waher J; Lidén G
    Inhal Toxicol; 2004 Jan; 16(1):45-52. PubMed ID: 14744664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats.
    Carvalho SR; Watts AB; Peters JI; Liu S; Hengsawas S; Escotet-Espinoza MS; Williams RO
    Eur J Pharm Biopharm; 2014 Sep; 88(1):136-47. PubMed ID: 24859653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine delivery to rats via lung alveolar region-targeted aerosol technology produces blood pharmacokinetics resembling human smoking.
    Shao XM; Xu B; Liang J; Xie XS; Zhu Y; Feldman JL
    Nicotine Tob Res; 2013 Jul; 15(7):1248-58. PubMed ID: 23239844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic intermittent nicotine delivery via lung alveolar region-targeted aerosol technology produces circadian pharmacokinetics in rats resembling human smokers.
    Shao XM; Liu S; Lee ES; Fung D; Pei H; Liang J; Mudgway R; Zhang J; Feldman JL; Zhu Y; Louie S; Xie XS
    J Appl Physiol (1985); 2018 Nov; 125(5):1555-1562. PubMed ID: 30236046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deconvolution of Systemic Pharmacokinetics Predicts Inhaled Aerosol Dosimetry of Nicotine.
    Kolli AR; Calvino-Martin F; Kuczaj AK; Wong ET; Titz B; Xiang Y; Lebrun S; Schlage WK; Vanscheeuwijck P; Hoeng J
    Eur J Pharm Sci; 2023 Jan; 180():106321. PubMed ID: 36336278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Dissolution of Poorly Soluble Compounds Studied in an ex Vivo Rat Lung Model.
    Eriksson J; Thörn H; Sjögren E; Holmstén L; Rubin K; Lennernäs H
    Mol Pharm; 2019 Jul; 16(7):3053-3064. PubMed ID: 31136181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
    Pai RV; Jain RR; Bannalikar AS; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
    Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
    Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y; Zhao M; Liu G; Tang X
    J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel apparatus for rat in vivo evaluation of dry powder formulations for pulmonary administration.
    Okamoto H; Aoki M; Danjo K
    J Pharm Sci; 2000 Aug; 89(8):1028-35. PubMed ID: 10906726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Delivery of Vancomycin Dry Powder Aerosol to Intubated Rabbits.
    Sullivan BP; El-Gendy N; Kuehl C; Berkland C
    Mol Pharm; 2015 Aug; 12(8):2665-74. PubMed ID: 25915095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model Calculations of Regional Deposition and Disposition for Single Doses of Inhaled Liposomal and Dry Powder Ciprofloxacin.
    Martin AR; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):49-60. PubMed ID: 28708440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.